TRAILR1/TNFRSF10A Antibody (TR1.02) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-80069PCP
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # TR1.02
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human TRAILR1/TNFRSF10A (DR4).
Specificity
Recognizes human TRAILR1/TNFRSF10A. Does not cross-react with human TRAIL-R2, -R3 or -R4.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for TRAILR1/TNFRSF10A Antibody (TR1.02) [PerCP]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TRAILR1/TNFRSF10A
Long Name
TRAIL Receptor 1
Alternate Names
CD261, DR4, TNFRSF10A, TRAIL R1
Gene Symbol
TNFRSF10A
Additional TRAILR1/TNFRSF10A Products
Product Documents for TRAILR1/TNFRSF10A Antibody (TR1.02) [PerCP]
Product Specific Notices for TRAILR1/TNFRSF10A Antibody (TR1.02) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...